DPP4 and diabetes mellitus: Our experimental investigations demonstrated that four bioactive peptides (GR-5, SA-6, VF-6, and IR-7) exhibited dose-dependent inhibitory effects on three critical diabetes-related enzymes: α-glucosidase, α-amylase, and DPP-IV.